Patents, Profits, and Pitfalls: Avoiding the Costliest Mistakes in U.S. Intellectual Property Strategy


 Intellectual property is not merely a legal asset—it's a financial instrument. Yet many U.S. companies fail to treat patents with the same rigour they apply to revenue forecasting, M&A strategy, or cost optimization. This negligence isn’t passive oversight. It reflects a deeper issue: patents are often disconnected from financial planning and operational strategy.
According to a 2024 IP Value Benchmarking Study, fewer than 12% of corporate patent portfolios generate direct revenue. That means the vast majority represent sunk costs—money spent on filing, maintenance, and legal fees without monetization.
For More Updates, Click Here.

Comments

Popular posts from this blog

Patent Infringement and IP Protection: Safeguarding Your Intellectual Property Rights. (Patentability Search)

The Role of Patents in the Pharmaceutical Industry: Patentability Search.

Intricate Research Partners with PQAI to Boost Patent Search and Innovation